WNS Holdings

WNS Holdings, a Mumbai-headquartered business process management company listed on the NYSE, had built its reputation primarily as an insurance and travel industry BPO specialist. By fiscal 2019 (ending March 2019), the company generated approximately $820 million in annual revenue, with insurance accounting for roughly 30% and travel for approximately 15% of the total. Healthcare and life sciences (HCLS) represented a much smaller share — approximately 10-12% of revenue. WNS recognized that its core insurance and travel verticals faced cyclical risk and volume concentration, while the global healthcare BPO market was growing at 10-12% annually, driven by payer complexity, regulatory burden, and clinical trial outsourcing. The company needed a deliberate entry strategy to scale healthcare from a minor vertical to a meaningful growth driver.

Between fiscal 2019 and fiscal 2023, WNS executed a multi-pronged market entry strategy into healthcare and life sciences:

• Targeted acquisitions: Acquired HealthHelp, a US-based utilization management company specializing in clinical decision support for health insurance payers, adding domain-specific capabilities and client relationships that WNS could not have built organically. This acquisition brought proprietary clinical algorithms and relationships with major US health plans.
• Domain talent investment: Hired over 200 healthcare domain specialists — including physicians, pharmacists, registered nurses, and clinical coders — into a dedicated HCLS practice, creating credibility with healthcare clients who demand deep regulatory and clinical expertise from BPO partners.
• Technology platform development: Built proprietary platforms for claims adjudication, prior authorization, and clinical trial data management, differentiating WNS from horizontal BPO competitors who offered generic process outsourcing without healthcare-specific automation.
• Strategic partnerships: Partnered with electronic health record (EHR) and health information exchange platforms to integrate WNS processes directly into provider and payer workflows, reducing friction for potential clients evaluating WNS as a new vendor.
• Organizational restructuring: In April 2023, reorganized from a geographic operating model to four strategic business units, establishing a dedicated HCLS vertical with its own P&L, leadership team, and go-to-market resources — signaling long-term commitment to the vertical.

• Healthcare revenue growth: HCLS grew from approximately 10-12% of total revenue in fiscal 2019 to 15.7% in fiscal 2022 and 17.7% in fiscal 2023, representing a near-doubling of the vertical's contribution over four years.
• Revenue scale: With total company revenue reaching approximately $1.2 billion in fiscal 2023, the HCLS vertical generated an estimated $195-$210 million annually, up from approximately $85-$100 million in fiscal 2019.
• Digital revenue concentration: 42% of WNS's digital revenue in fiscal 2023 came from healthcare and travel verticals combined, indicating that HCLS was a primary driver of the company's higher-value technology-led engagements.
• Strategic technology investments: Total strategic investments reached $62.4 million in fiscal 2023, with a significant portion directed toward healthcare technology platforms and capabilities.
• Overall company growth: Total revenue grew from $820 million (FY2019) to $1.2 billion (FY2023), with healthcare as one of the fastest-growing verticals contributing to the 16%+ constant currency growth rate in fiscal 2022.
• Timeframe: Vertical build-out executed over fiscal 2019-2023 (April 2018 to March 2023).

• WNS's existing insurance BPO expertise provided adjacent domain knowledge (claims processing, regulatory compliance) that transferred to healthcare payer operations
• India-based delivery model offered 40-60% cost arbitrage for healthcare administrative functions that US payers were increasingly willing to offshore post-COVID
• HealthHelp acquisition provided immediate credibility with US health plans that would have taken 3-5 years to build organically
• Regulatory tailwinds: increasing CMS complexity and prior authorization requirements expanded the addressable market for healthcare BPO services